US Bancorp’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.13K Hold
611
﹤0.01% 3789
2025
Q4
$2.09K Sell
611
-864
-59% -$3.86K ﹤0.01% 3749
2025
Q3
$7.42K Buy
1,475
+87
+6% +$383 ﹤0.01% 3411
2025
Q2
$4.76K Sell
1,388
-1,616
-54% -$4.02K ﹤0.01% 3654
2025
Q1
$6.7K Buy
3,004
+1,048
+54% +$3.01K ﹤0.01% 3568
2024
Q4
$5.73K Buy
1,956
+460
+31% +$1.28K ﹤0.01% 3609
2024
Q3
$3.89K Sell
1,496
-100
-6% -$277 ﹤0.01% 3651
2024
Q2
$4.72K Sell
1,596
-1,359
-46% -$5.14K ﹤0.01% 3531
2024
Q1
$13.4K Hold
2,955
﹤0.01% 3233
2023
Q4
$16.9K Buy
2,955
+721
+32% +$3.34K ﹤0.01% 3128
2023
Q3
$10.3K Buy
2,234
+18
+0.8% +$110 ﹤0.01% 3166
2023
Q2
$14.3K Buy
2,216
+1,060
+92% +$7.23K ﹤0.01% 3128
2023
Q1
$8.72K Sell
1,156
-274
-19% -$2.49K ﹤0.01% 3334
2022
Q4
$14.5K Buy
1,430
+1,360
+1,943% +$15.7K ﹤0.01% 3165
2022
Q3
$1K Buy
+70
New +$768 ﹤0.01% 3902
2021
Q3
Sell
-500
Closed -$11K 4056
2021
Q2
$11K Buy
500
+416
+495% +$11.5K ﹤0.01% 3356
2021
Q1
$3K Buy
+84
New +$3.35K ﹤0.01% 3586

Other funds holding ABCL